U.S. House of Representatives: Committee on Energy and Commerce, Republicans

Subcommittee on Health
June 13, 2001
10:00 AM
2322 Rayburn House Office

The free Real Player basic is required in order to connect to this broadcast.

Panel 1
Ms. Janet Woodcock M.D. Director Food and Drug Administration Center for Drug Evaluation and Research 1451 Rockville Pike Rockville, Maryland, 20857

Panel 2
Mr. Gregory Glover M.D. Partner Ropes & Gray On Behlf of Pharmaceutical Researchers and Manufacturers of America 1301 K Street, N.W. Suite 800 Washington, DC, 20005	Mr. Bruce Downey Chairman and CEO Barr Laboratories On behalf of : The Generic Pharmaceutical Association 444 North Capitol Street, N.W. Suite 722 Washington, DC, 20001
Ms. Jane L. Delgado PH.D., M.S. President and CEO National Alliance for Hispanic Health 1501 16th Street, N.W. Washington, DC, 20036	Mr. John D. Golenski Executive Director Rx Health Value 625 Indiana Avenue Washington, DC, 20004
Mr. Thomas Geiser General Counsel WellPoint Health Networks Accompanied by Dr. Robert Seidman Vice President, Pharmacy 1455 Pennsylvania Avenue, N.W. Suite 575 Washington, DC, 20004	Mr. Richard F. Kingham Partnet Covington & Burling 1201 Pennsylvania Avenue Washington, DC, 20004

The printed transcript of this hearing is available in both Adobe Acrobat and text/html versions.

Click here to access the Adobe Acrobat version. You will need to the free Adobe Acrobat Reader to view this document. You can download the free Adobe Reader here.

Click here to access the text/html version. The text only version omits items, such charts, graphs and other documents that are part of the official printed hearing record.

The Honorable Billy Tauzin

The Honorable Michael Bilirakis

Recent Developments Which May Impact Consumer Access to, and Demand for, Pharmaceuticals